YDL223C (HBT1): Revolutionizing Cognitive Function and Neuroprotection
Discover the potential of YDL223C, a novel AMPA-R potentiator for enhanced brain function and therapeutic applications.
Get a Quote & SampleProduct Core Value
YDL223C
YDL223C, also known as HBT1, stands out as a novel and potent potentiator of AMPA-R. This compound is engineered to enhance brain function by inducing the production of brain-derived neurotrophic factor (BDNF). It demonstrates significant potential in improving memory, focus, creativity, and overall intelligence, making it a valuable asset in the field of nootropics and cognitive enhancement. Furthermore, YDL223C is being explored for its therapeutic efficacy in the prevention and treatment of complex neurological conditions such as schizophrenia, autism, and Alzheimer's disease.
- Leveraging YDL223C AMPA-R potentiator research, this compound can significantly improve cognitive functions and memory recall.
- Investigate the therapeutic benefits of HBT1 brain function enhancement in preclinical and clinical studies for neurodegenerative disorders.
- Explore the role of BDNF induction compound in promoting neuronal growth and survival, crucial for neuroprotection strategies.
- Source high-purity YDL223C as a critical API for the development of next-generation cognitive enhancer APIs.
Key Advantages of YDL223C
Cognitive Enhancement
YDL223C significantly boosts cognitive functions such as memory and focus, making it a prime candidate for improving learning ability as part of a comprehensive neuroprotection drug development approach.
Neurotherapeutic Potential
The compound's ability to induce BDNF production offers promising avenues for treating neurological conditions, aligning with Alzheimer's disease treatment research and other CNS disorders.
High Purity and Quality
Available with 99% purity, YDL223C meets stringent pharmaceutical standards, ensuring reliable and effective results in research and development applications.
Key Applications
Cognitive Function Improvement
YDL223C enhances memory, attention, and learning capacity, making it a valuable tool for those seeking to optimize brain performance through cognitive enhancer APIs.
Neurodegenerative Disease Research
As an API, YDL223C is crucial in research for conditions like Alzheimer's, leveraging its BDNF induction and neuroprotection capabilities.
Schizophrenia and Autism Studies
The unique action of HBT1 as an AMPA-R potentiator is being explored in the context of schizophrenia and autism treatment research.
Pharmaceutical Intermediate
YDL223C serves as a vital intermediate in the synthesis of advanced pharmaceutical compounds for various neurological and cognitive applications.